Venetoclax medical insurance reimbursement scope and patients’ actual reimbursement amount

Venetoclax, a small molecule inhibitor targeting BCL-2, has been officially launched in China and has been included in the medical insurance catalog, which means that eligible patients can enjoy the medical insurance reimbursement policy when purchasing it from regular medical institutions. The inclusion of medical insurance has greatly reduced the financial burden on patients, allowing more patients to obtain continuous treatment opportunities, which is especially important for patients with chronic lymphocytic leukemia (CLL) and certain acute myeloid leukemia (AML).

According to domestic hospital pharmacy information, the common specifications of venetoclax are100mg*28 tablets, and the price per box is about 2,000 yuan. After being included in medical insurance, patients can be reimbursed for part of the expenses according to local medical insurance policies, provided they meet the reimbursement conditions. The specific reimbursement amount will vary according to the city where the patient is located, the type of medical insurance and hospital policies. It is generally around 50% to 70%, which greatly reduces the cost of treatment. Patients need to consult the hospital pharmacy before purchasing to ensure smooth medication and reimbursement processes.

In the international market, the price of venetoclax varies greatly. In foreign markets, there are generic drugs from Laos and Bangladesh. The price of 100mg*120 tablets is about more than a thousand yuan, which is much cheaper than domestically imported original drugs. Small packaging options of different specifications are also provided, with prices ranging from a few hundred yuan. The ingredients of these generic drugs are basically the same as those of domestic original drugs, but when purchasing, you need to ensure regular channels to avoid the risk of fake drugs or substandard quality.

In general, after Venetoclax is included in medical insurance, domestic patients can enjoy reimbursement policies when purchasing it from regular medical institutions, reducing their financial burden. In the international market, generic drugs provide relatively low-cost medication options, but attention must still be paid to the source and quality of the drugs. Before using venetoclax, patients should fully understand the medical insurance policy and actual reimbursement amount, follow the doctor's instructions, and reasonably plan the medication plan to obtain the best treatment effect.

Reference materials:https://www.drugs.com/